← Leaderboards
Yanhong Guo
University Of Michigan At Ann Arbor
$3,232,365
Attributed
$4,411,296
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$4,411,296 · 2
By mechanism
R01$4,411,296 · 2
Top collaborators
- Anna Schwendeman4 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Yuqing E Chen$44,993,151
- Luis Villacorta$2,232,929
- Andrea Todisco$5,266,661
- Clifton W Callaway$17,248,303
- Katherine Ann Gallagher$14,068,065
Others in their field
Other Rising Stars on “Rupture”
- Bradley David Allen · Northwestern University At Chicago$2,765,332
- Chung-Hao Lee · University Of Oklahoma$2,707,566
- Ryan Daniel Sochol · Infratrac, Inc.$2,683,863
- Huimahn Alex Choi · University Of Texas Hlth Sci Ctr Houston$2,190,103
- Christian Kastrup · Versiti Wisconsin, Inc.$2,182,730
- Eni Halilaj · Carnegie-Mellon University$2,179,833
Research focus
RupturePathogenesisVascular Smooth MuscleSmooth Muscle MyocytesPlayAbdominal Aortic AneurysmProtective EffectVascular InflammationMouse ModelAortaExtracellular Matrix DegradationAneurysmHuman GeneticsGrowthAbdominal AortaOperative Surgical ProceduresDissectionDeath RateAdultLesionNew Therapeutic TargetMortalityElastasesAnimal Model
Grant awards (7)
Development of phospholipid-based nanotherapeutics for treating abdominal aortic aneurysm$763,935
R01 · FY2025 · HL · contact PI
Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm$689,072
R01 · FY2025 · HL · contact PI
Development of phospholipid-based nanotherapeutics for treating abdominal aortic aneurysm$748,657
R01 · FY2024 · HL · contact PI
Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm$675,290
R01 · FY2024 · HL · contact PI
Development of phospholipid-based nanotherapeutics for treating abdominal aortic aneurysm$81,335
R01 · FY2024 · HL · contact PI
Development of phospholipid-based nanotherapeutics for treating abdominal aortic aneurysm$763,935
R01 · FY2023 · HL · contact PI
Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm$689,072
R01 · FY2023 · HL · contact PI